Showing results (2881-2890 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Auto-tumor lysis by blood lymphocytes in vitro. Strongly activated lymphocytes lack selectivityF Vánky, E Klein
Cancer Immunology, Immunotherapy : CII|April 9, 2014
Effective TRAIL-based immunotherapy requires both plasmacytoid and CD8α dendritic cellsBritnie R James, Erik L Brincks, Tamara A Kucaba, et al.
Cancer Immunology, Immunotherapy : CII|March 21, 2014
Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunityValentina Rigo, Maria Valeria Corrias, Anna Maria Orengo, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2014
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancerRoheena Z Panni, Dominic E Sanford, Brian A Belt, et al.
Cancer Immunology, Immunotherapy : CII|April 1, 2014
Immunomodulatory activity of commonly used drugs on Fc-receptor-mediated human natural killer cell activationJakob Theorell, Anna-Lena Gustavsson, Bianca Tesi, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Production of cytokines after lipopolysaccharide stimulation of murine spleen cells during lymphoma development in AKR miceD Vaillier, R Daculsi, E Legrand, et al.
Cancer Immunology, Immunotherapy : CII|April 4, 2014
Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?Karīna Siliņa, Undīne Rulle, Zane Kalniņa, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Signalling pathway of tumor necrosis factor in normal and tumor cellsN Watanabe, H Neda, Y Ohtusuka, et al.
Cancer Immunology, Immunotherapy : CII|March 27, 2014
Combining trastuzumab and cetuximab combats trastuzumab-resistant gastric cancer by effective inhibition of EGFR/ErbB2 heterodimerization and signalingLei Zheng, Wenlong Tan, Jinrong Zhang, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2016
Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinomaCheng Chen, Kesang Li, Hua Jiang, et al.
Pageof 652